Still another activity by the highly promiscuous enzyme CYP3A4: 25-Hydroxylation of cholesterol

Journal of Lipid Research

Volumn 52, Issue 8, 2011, Pages 1447-1449

  Diczfalusy, Ulf ^a   Björkhem, Ingemar ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYCHOLESTEROL; 4BETA HYDROXYCHOLESTEROL; CARBAMAZEPINE; CHOLESTEROL 25 HYDROXYLASE; CHOLESTEROL DERIVATIVE; CYTOCHROME P450 3A4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NIFEDIPINE; OXYGENASE; QUINIDINE; UNCLASSIFIED DRUG;

CATALYSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; DRUG MECHANISM; DRUG SAFETY; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SPECIFICITY; HUMAN; LIPID ANALYSIS; LIPID OXIDATION; NONHUMAN; NOTE; PRIORITY JOURNAL; SIDE EFFECT; STEROID HYDROXYLATION; TISSUE DISTRIBUTION;

ANIMALS; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME ACTIVATION; HEPATOCYTES; HUMANS; HYDROXYCHOLESTEROLS; LIPID METABOLISM; LIVER;

EID: 79960685039     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.E017806     Document Type: Note

References (15)

1. Diczfalusy, U., K. E. Olofsson, A-M. Carlsson, M. Gong, D. T. Golenbock, O. Rooyackers, U. Fläring, and H. Björkbacka. 2009. Marked up-regulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. J. Lipid Res. 50: 2258-2264.
2. Bauman, D. R., A. D. Bitmansour, J. G. McDonald, B. M. Thompson, G. Liang, and D. W. Russell. 2009. 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production. Proc. Natl. Acad. Sci. USA. 106: 16764-16769.
3. Lund, E. G., T. A. Kerr, J. Sakai, W-P. Li, and D. W. Russell. 1998. cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. J. Biol. Chem. 273: 34316-34327.
4. Lund, E., I. Björkhem, C. Furster, and K. Wikvall. 1993. 24-, 25- and 27-hydroxylation of cholesterol by a purified preparation of 27-hydroxylase from pig liver. Biochim. Biophys. Acta. 1166: 177-182. (Pubitemid 23060891)
5. Lund, E. G., J. M. Guileyardo, and D. W. Russell. 1999. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. USA. 96: 7238-7243.
6. Smith, L. L. 1981. Cholesterol autoxidation. Plenum Press, New York. 1-12.
7. Honda, A., T. Miyazaki, T. Ikegami, J. Iwamoto, T. Maeda, T. Hirayama, Y. Saito, T. Teramoto, and Y. Matsuzaki. 2011. Cholesterol 25-hydroxylation activity of CYP3A4. J. Lipid Res. 52: 1509-1516.
8. Diczfalusy, U., H. Nylén, P. Elander, and L. Bertilsson. 2011. 4 b -Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans. Br. J. Clin. Pharmacol. 71: 183-189.
9. Furster, C., and K. Wikvall. 1999. Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5β-cholestane-3α, 7α, 12α-triol in human liver microsomes. Biochim. Biophys. Acta. 1437: 46-52. (Pubitemid 29242902)
10. Gupta, R. P., Y. A. He, K. S. Patrick, J. R. Halpert, and N. H. Bell. 2005. CYP3A4 is a vitamin D-24- and 25-hydroxylase: analysis of structure function by site-directed mutagenesis. J. Clin. Endocrinol. Metab. 90: 1210-1219.
11. Ekroos, M., and T. Sjögren. 2006. Structural basis for ligand promiscuity in cytochrome P450 3A4. Proc. Natl. Acad. Sci. USA. 103: 13682-13687. (Pubitemid 44413967)
12. Shinkyo, R., and F. P. Guengerich. 2011. Inhibition of human cytochrome P450 3A4 by cholesterol. J. Biol. Chem. 286: 18426-18433.
13. Babiker, A., and U. Diczfalusy. 1998. Transport of side-chain oxidized oxysterols in the human circulation. Biochim. Biophys. Acta. 1392: 333-339. (Pubitemid 28287335)
14. Bodin, K., L. Bretillon, Y. Aden, L. Bertilsson, U. Broomé, C. Einarsson, and U. Diczfalusy. 2001. Antiepileptic drugs increase plasma levels of 4β-hydroxycholesterol in humans. Evidence for involvement of cytochrome P450 3A4. J. Biol. Chem. 276: 38685-38689.
15. Wide, K., H. Larsson, L. Bertilsson, and U. Diczfalusy. 2008. Time course of the increase in 4β-hydroxycholesterol concentration during carbamazepine treatment of pediatric patients with epilepsy. Br. J. Clin. Pharmacol. 65: 708-715. (Pubitemid 351535081)